Overall leader Aleksandr Vlasov tested positive the day after winning the fifth stage, the Russian rider’s team said. Bora-Hansgrohe team member Anton Palzer also tested positive on Friday morning.
The Alpecin-Fenix, Bahrain Victorious and UAE Team Emirates teams also withdrew from the sixth stage from Locarno to Moosalp on Friday, one day after the Jumbo-Visma squad left the eight-day race, which finishes Sunday.
Swiss rider Marc Hirschi of UAE Team Emirates also tested positive and is out of the race, while his roommate, Joel Suter, was withdrawn as a precaution, the team said.
“Unfortunately, like many other teams we have also had a surge in Covid-19 cases,” UAE team medical director Adrian Rotunno said.
The Israel Premier Tech and Education EF teams have also withdrawn several riders.
Tour de Suisse organisers have decided to continue the race despite the growing number of Covid-19 cases. The Swiss race is one of the last events to prepare for the three-week Tour de France, which starts in two weeks.
Surge in new sub-variant infections
European countries are experiencing a surge in Covid-19 cases driven by the BA.4 and BA.5 sub-variants of the highly infectious Omicron strain, threatening a fresh global wave of the disease.
Most European countries have so far detected low rates of the two subgroups. But in countries where the proportion has risen – such as Portugal – there have been surges in overall cases, the European Centre for Disease Prevention and Control said on June 13.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Switzerland announced the lifting of all remaining Covid-19 pandemic restrictions as of April 1. However, after three months of falling infections, new coronavirus infections have started rising again slightly, most likely due to two new Omicron subvariants, BA.4 and BA.5. A total of 16,610 new cases were reported on June 14 for the previous seven-day period. The seven-day daily average for new infections stood at 2,124, up 45% on the previous week.
BA.4 and BA.5 do not appear to carry a higher risk of severe disease than other forms of Omicron. But an increase in case numbers from higher transmission rates risks leading to an increase in hospitalisations and deaths, the ECDC said.
Popular Stories
More
Life & Aging
Zurich: how the world capital of housing shortages is tackling the problem
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
This content was published on
Switzerland's dioceses are making arrangements for the faithful to attend the Pope's funeral, including public screenings.
Vulnerable tenants hit hardest by Zurich evictions
This content was published on
More tenants are evicted in Zurich than anywhere else in Switzerland, which particularly affects older people on low incomes.
This content was published on
Swiss National Bank Q1 profits weighed down by foreign currency investments, which the rise in gold was unable to offset.
Men in Switzerland under pressure to uphold social standing
This content was published on
A study from the University of Bern reveals that men in relatively gender-equal countries face significant pressure to maintain their high social status.
Ivory Coast court bars former Credit Suisse CEO from presidential race
This content was published on
The court removed opposition politician and former CEO of Credit Suisse Tidjane Thiam from the electoral roll, citing the loss of his Ivorian nationality.
Novartis and Sanofi call for higher drug prices in Europe
This content was published on
Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.